A critical medicines act for Europe
Introduction Over the past few decades, Europe’s manufacturing base for off-patent medicines, APIs, and starting materials has gradually decreased. This
Read moreIntroduction Over the past few decades, Europe’s manufacturing base for off-patent medicines, APIs, and starting materials has gradually decreased. This
Read moreAs discussions surrounding the revision of the EU pharmaceutical legislation take place, two fundamental questions come to the forefront: how
Read moreSince 2020, the COVID pandemic altered every part of our lives, our societies, and our economies. It caught the world
Read moreThe COVID-19 crisis has pushed health higher on the agenda of the European Union, but also on the list of
Read more“The science is clear. Industrial carbon removal is a necessary part of our climate toolbox” Ursula von der Leyen, European
Read moreAir Liquide’s decarbonisation solutions are key to addressing climate emergency, while contributing to EU’s industrial renewal and sovereignty. Molecules such
Read morePorts will be key hubs for the integration of hydrogen into Europe’s energy mix. However, according to a first report
Read moreEuropean Commission presented it’s proposal for Critical Raw Materials Act 16th of March 2023. To boost EU autonomy, the European
Read more